✦ LIBER ✦

Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis

✍ Scribed by F. FABRIZI; V. DIXIT; P. MARTIN

Book ID: 108604679
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 531 KB
Volume: 24
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2006.03041.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis: oral anti-viral agents in

Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis

✍ A. K. Singal; R. J. Fontana 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

Meta-analysis: anti-viral therapy of hep

Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients

✍ F. FABRIZI; G. LUNGHI; V. DIXIT; P. MARTIN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Effect of anti-viral therapy for occult

Effect of anti-viral therapy for occult hepatitis C virus infection

✍ M. PARDO; J. M. LÓPEZ-ALCOROCHO; I. CASTILLO; E. RODRÍGUEZ-IÑIGO; A. PEREZ-MOTA; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Meta-analysis: the efficacy of anti-vira

Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma

✍ J. S.-W. Wong; G. L.-H. Wong; K. K.-F. Tsoi; V. W.-S. Wong; S. Y.-S. Cheung; C.- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

Predictors of relapse in chronic hepatit

Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy

✍ Y. Liang; J. Jiang; M. Su; Z. Liu; W. Guo; X. Huang; R. Xie; S. Ge; J. Hu; Z. Ji 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

Therapy of hepatitis C: Meta-analysis of

Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials

✍ R L Carithers Jr; S S Emerson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

We performed an independent meta-analysis of all available blind, placebo-controlled trials confirmed the efficacy of this randomized clinical trials of interferon alfa-2b in patients with agent in normalizing alanine aminotransferase (ALT) values chronic hepatitis C. Articles published between 1986